Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on Screening, Verification and Intervention of High-risk Patients With Liver Cancer

NCT05721300 is registered in ClinicalTrials.gov with Zhongshan Hospital (Xiamen), Fudan University as lead sponsor.

NCT NCT05721300
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05721300 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on Screening, Verification and Intervention of High-risk Patients With Liver Cancer
Lead sponsor
Zhongshan Hospital (Xiamen), Fudan University
Phase
Not applicable
Overall status
Unknown status
Start date
February 10, 2023
Completion date
December 31, 2024
Enrollment
2,215 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b, hepatocellular carcinoma